Agios Pharmaceuticals | AGIO - PE Price to Earnings


Agios Pharmaceuticals reported 3.56 in PE Price to Earnings for its fiscal quarter ending in September of 2025.





Pe Change Date
AbbVie 24.03 86.23 Dec/2025
Agios Pharmaceuticals 3.56 0.68 Sep/2025
Alnylam Pharmaceuticals 170.7 367.33 Dec/2025
Amgen 25.31 15.82 Dec/2025
Astellas Pharma 7.31 2.04 Dec/2025
AstraZeneca 27.29 5.8 Dec/2025
Bayer 5.93 0.68 Sep/2025
Biogen 14.02 4.63 Dec/2025
BioMarin Pharmaceutical 19.24 0.21 Dec/2025
Bristol-Myers Squibb 9.28 1.04 Dec/2025
Daiichi Sankyo 20.73 1.74 Dec/2025
Eli Lilly 40.21 9.66 Dec/2025
Exelixis 602.31 586.25 Dec/2025
Gilead Sciences 15.63 0.08 Dec/2025
GlaxoSmithKline 11.15 0.29 Dec/2025
Incyte 14.84 2.79 Dec/2025
Ionis Pharmaceuticals 396.15 79.28 Sep/2022
Merck 13.92 5.08 Dec/2025
Moderna 27.22 14.51 Jun/2023
Novartis 15.74 0.15 Sep/2025
Novartis 16.05 2.92 Sep/2025
Pfizer 14.48 5.18 Dec/2025
Puma Biotechnology 13.93 44.88 Jun/2024
Regeneron Pharmaceuticals 18.11 2.91 Dec/2025
Roche Holding 16.09 3.51 Dec/2025
Sarepta Therapeutics 27.27 0 Sep/2025
Vertex Pharmaceuticals 26.15 2.22 Dec/2025